Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ángel Marcos Fendian (Ángel Marcos-Fendian)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Patient Reported

Multidrug Resistant

Ejection Fraction

Top Venues

Infectious diseases and therapy

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Lucía Vallez-Valero, Ingrid Gasó-Gago, Ángel Marcos Fendian, Gemma Garrido-Alejos, Adrià Riera-Magallón, Adrián Plaza Diaz, Cristina Martinez-Molina, Maria Antonia Mangues, Hèctor Corominas
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. Clinical rheumatology (2023)
Ángel Marcos Fendian, Marta Albanell, Montse Tuset, Cristina Pitart, Pedro Castro, Dolors Soy, Marta Bodro, Alex Soriano, Ana Del Río, José Antonio Martínez
Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infectious diseases and therapy (2023)
Ángel Marcos Fendian, Marta Albanell, Montse Tuset, Cristina Pitart, Pedro Castro, Dolors Soy, Marta Bodro, Alex Soriano, Ana Del Río, José Antonio Martínez
Real-Life Data on the Effectiveness and Safety of Cefiderocol in Severely Infected Patients: A Case Series. Infectious diseases and therapy (2023)